Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TKHGV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BG-C9074
|
|||||
| Synonyms |
BG-C9074; BG C9074; BGC9074; DB 1312; DB-1312; DB1312
Click to Show/Hide
|
|||||
| Organization |
Duality Biologics
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
6
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
V-set domain-containing T-cell activation inhibitor 1 (VTCN1)
|
Antigen Info | ||||
| Payload Name |
DNA topoisomerase-I inhibitor
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random Cysteines
|
|||||
